Entering text into the input field will update the search result below

GlaxoSmithKline CEO Walmsley's 2021 pay rises Y/Y on back of bonus

Mar. 07, 2022 4:57 AM ETGSK plc (GSK)NVS, RHHBY, RHHBFBy: Ravikash, SA News Editor5 Comments

GlaxoSmithKline in Dresden

13threephotography/iStock Editorial via Getty Images

  • GlaxoSmithKline (NYSE:GSK) CEO Emma Walmsley's 2021 total remuneration rose to £8.20M, compared to £7.03M in 2020.
  • The increase was mainly due to a rise in total pay for performance, which grew +21.21% Y/Y to £6.60M in 2021.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.